Role of two-component systems in the resistance of Staphylococcus aureus to antibacterial agents

Virulence

Volumn 2, Issue 5, 2011, Pages 427-430

  Kawada Matsuo, Miki ^a   Yoshida, Yuuma ^a   Nakamura, Norifumi ^a   Komatsuzawa, Hitoshi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

ABC transporter; Bacitracin; Staphylococcus aureus; Two component sytem

Indexed keywords

4 [1 [[BIS(4 METHYLPHENYL)METHYL]CARBAMOYL] 3 (2 ETHOXYBENZYL) 4 OXO 2 AZETIDINYLOXY]BENZOIC ACID; ABC TRANSPORTER; ANTIINFECTIVE AGENT; BACITRACIN; BACTERIOCIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; GENTAMICIN; PHOSPHATIDYLGLYCEROL; VANCOMYCIN; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACILLUS LICHENIFORMIS; BACTERIAL CELL WALL; BACTERIAL SURVIVAL; BIOSYNTHESIS; CELL SURFACE; ENTEROCOCCUS FAECALIS; ENVIRONMENTAL CHANGE; GENE TRANSFER; NONHUMAN; OPERON; R FACTOR; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS AUREUS;

EID: 80053900722     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.2.5.17711     Document Type: Article

References (30)

1. Grundmann H, Aires-de-Sousa M, Boyce J, Tiemersma E. Emergence and resurgence of meticillin- resistant Staphylococcus aureus as a public-health threat. Lancet 2006; 368:874-885 PMID:16950365; http://dx.doi.org/10.1016/S0140-6736(06)68853-3.
2. Howden BP, Davies JK, Johnson PD, Stinear TP, Grayson ML. Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection and clinical implications. Clin Microbiol Rev 2010; 23:99-139 PMID:20065327; http://dx.doi. org/10.1128/CMR.00042-09.
3. Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, Downes FP, et al. Infection with vancomycin- resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 2003; 348:1342-1347 PMID:12672861; http://dx.doi.org/10.1056/ NEJMoa025025.
4. Berman DS, Eisner W, Kreiswirth B. Communityacquired methicillin-resistant Staphylococcus aureus infection. N Engl J Med 1993; 329:1896 PMID:8247050; http://dx.doi.org/10.1056/ NEJM199312163292517.
5. Ito T, Okuma K, Ma XX, Yuzawa H, Hiramatsu K. Insights on antibiotic resistance of Staphylococcus aureus from its whole genome: genomic island SCC. Drug Resist Updat 2003; 6:41-52 PMID:12654286; http://dx.doi.org/10.1016/S1368-7646(03)00003-7.
6. Kuroda M, Kuroda H, Oshima T, Takeuchi F, Mori H, Hiramatsu K. Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus. Mol Microbiol 2003; 49:807-821 PMID:12864861; http://dx.doi. org/10.1046/j.1365-2958.2003.03599.x.
7. Meehl M, Herbert S, Gotz F, Cheung A. Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycinintermediate resistance in Staphylococcus aureus. Antimicrob Agents Chemother 2007; 51:2679-2689 PMID:17502406; http://dx.doi.org/10.1128/ AAC.00209-07.
8. Sakoulas G, Eliopoulos GM, Moellering RC Jr, Wennersten C, Venkataraman L, Novick RP, et al. Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin. Antimicrob Agents Chemother 2002; 46:1492-502 PMID:11959587; ht tp://d x.doi.org /10.1128 /A AC.46.5.1492-502.2002.
9. Novick RP. Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol Microbiol 2003; 48:1429-49 PMID:12791129; http://dx.doi.org/10.1046/j.1365- 2958.2003.03526.x.
10. Matsuo M, Kato F, Oogai Y, Kawai T, Sugai M, Komatsuzawa H. Distinct two-component systems in methicillin-resistant Staphylococcus aureus can change the susceptibility to antibacterial agents. J Antimicrob Chemother 2010; 65:1536-7 PMID:20430791; http://dx.doi.org/10.1093/jac/dkq141.
11. Ohki R, Giyanto, Tateno K, Masuyama W, Moriya S, Kobayashi K, et al. The BceRS two-component regulatory system induces expression of the bacitracin transporter, BceAB, in Bacillus subtilis. Mol Microbiol 2003; 49:1135-44.
12. Podlesek Z, Comino A, Herzog-Velikonja B, Zgur- Bertok D, Komel R, Grabnar M. Bacillus licheniformis bacitracin-resistance ABC transporter: relationship to mammalian multidrug resistance. Mol Microbiol 1995; 16:969-76 PMID:7476193; http://dx.doi.org/10.1111/j.1365-2958.1995.tb02322.x.
13. Manson JM, Keis S, Smith JM, Cook GM. Acquired bacitracin resistance in Enterococcus faecalis is mediated by an ABC transporter and a novel regulatory protein, BcrR. Antimicrob Agents Chemother 2004; 48:3743-8 PMID:15388429; http://dx.doi. org/10.1128/AAC.48.10.3743-8.2004.
14. Tsuda H, Yamashita Y, Shibata Y, Nakano Y, Koga T. Genes involved in bacitracin resistance in Streptococcus mutans. Antimicrob Agents Chemother 2002; 46:3756-64 PMID:12435673; http://dx.doi. org/10.1128/AAC.46.12.3756-64.2002.
15. Blake KL, Randall CP, O'Neill AJ. In vitro studies indicate a high resistance potential for the lantibiotic nisin in Staphylococcus aureus and define a genetic basis for nisin resistance. Antimicrob Agents Chemother 2011; 55:2362-2368 PMID:21300840; http://dx.doi.org/10.1128/AAC.01077-10.
16. Kolar SL, Nagarajan V, Oszmiana A, Rivera FE, Miller HK, Davenport JE, et al. NsaRS is a cellenvelope- stress sensing two-component system of Staphylococcus aureus. Microbiology 2011; 157:2206-22019 PMID:21565927; http://dx.doi.org/10.1099/ mic.0.049692-0.
17. Gebhard S, Mascher T. Antimicrobial peptide sensing and detoxification modules: unravelling the regulatory circuitry of Staphylococcus aureus. Mol Microbiol 2011; 81:581-7 PMID:21696467; http:// dx.doi.org/10.1111/j.1365-2958.2011.07747.x.
18. Hiron A, Falord M, Valle J, Débarbouillé M, Msadek T. Bacitracin and nisin resistance in Staphylococcus aureus: a novel pathway involving the BraS/BraR two-component system (SA2417/SA2418) and both the BraD/BraE and VraD/VraE ABC transporters. Mol Microbiol 2011; 81:602-22 PMID:21696458; http://dx.doi.org/10.1111/j.1365-2958.2011.07735.x.
19. Breukink E, de Kruijff B. The lantibiotic nisin, a special case or not? Biochim Biophys Acta 1999; 1462:223-34 PMID:10590310; http://dx.doi. org/10.1016/S0005-2736(99)00208-4.
20. van Heusden HE, de Kruijff B, Breukink E. Lipid II induces a transmembrane orientation of the poreforming peptide lantibiotic nisin. Biochemistry 2002; 41:12171-8 PMID:12356318; http://dx.doi. org/10.1021/bi026090x.
21. Johnson BA, Anker H, Meleney FL. Bacitracin: A New antibiotic produced by a member of the B. subtilis group. Science 1945; 102:376-377 PMID:17770204; http://dx.doi.org/10.1126/science.102.2650.376.
22. Stone KJ, Strominger JL. Mechanism of action of bacitracin: complexation with metal ion and C 55-isoprenyl pyrophosphate. Proc Natl Acad Sci USA 1971; 68:3223-3227 PMID:4332017; http://dx.doi. org/10.1073/pnas.68.12.3223.
23. Chalker AF, Ingraham KA, Lunsford RD, Bryant AP, Bryant J, Wallis NG, et al. The bacA gene, which determines bacitracin susceptibility in Streptococcus pneumoniae and Staphylococcus aureus, is also required for virulence. Microbiology 2000; 146:1547-53 PMID:10878119.
24. Li M, Cha DJ, Lai Y, Villaruz AE, Sturdevant DE, Otto M. The antimicrobial peptide-sensing system aps of Staphylococcus aureus. Mol Microbiol 2007; 66:1136-47 PMID:17961141; http://dx.doi. org/10.1111/j.1365-2958.2007.05986.x.
25. Falord M, Mäder U, Hiron A, Débarbouillé M, Msadek T. Investigation of the Staphylococcus aureus GraSR regulon reveals novel links to virulence, stress response and cell wall signal transduction pathways. PLoS ONE 2011; 6:21323 PMID:21765893; http://dx.doi.org/10.1371/journal.pone.0021323.
26. Howden BP, Stinear TP, Allen DL, Johnson PD, Ward PB, Davies JK. Genomic analysis reveals a point mutation in the two-component sensor gene graS that leads to intermediate vancomycin resistance in clinical Staphylococcus aureus. Antimicrob Agents Chemother 2008; 52:3755-62 PMID:18644967; http://dx.doi.org/10.1128/AAC.01613-07.
27. Peschel A, Otto M, Jack RW, Kalbacher H, Jung G, Gotz F. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins and other antimicrobial peptides. J Biol Chem 1999; 274:8405-10 PMID:10085071; http:// dx.doi.org/10.1074/jbc.274.13.8405.
28. Peschel A, Jack RW, Otto M, Collins LV, Staubitz P, Nicholson G, et al. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J Exp Med 2001; 193:1067-76 PMID:11342591; http://dx.doi. org/10.1084/jem.193.9.1067.
29. Matsuo M, Oogai Y, Kato F, Sugai M, Komatsuzawa H. Growth-phase dependence of susceptibility to antimicrobial peptides in Staphylococcus aureus. Microbiology 2011; 157:1786-97 PMID:21393369; http://dx.doi.org/10.1099/mic.0.044727-0.
30. Gardete S, Wu SW, Gill S, Tomasz A. Role of VraSR in antibiotic resistance and antibiotic-induced stress response in Staphylococcus aureus. Antimicrob Agents Chemother 2006; 50:3424-34 PMID:17005825; http://dx.doi.org/10.1128/AAC.00356-06.